Allergan's total product sales increased by 7.2 percent in the fourth quarter ended Dec. 31 to $1,382.8 million on a net basis, up by 8.2 percent on a currency-neutral basis. Also in terms of constant currencies, sales of specialty pharmaceuticals went up by 10.1 percent, while those of medical devices ...

Buying a membership today will give you:
To continue reading this article register now.